Matches in Wikidata for { <http://www.wikidata.org/entity/Q87232347> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q87232347 description "article scientifique publié en 2016" @default.
- Q87232347 description "artículu científicu espublizáu en febreru de 2016" @default.
- Q87232347 description "im Februar 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87232347 description "scientific article published on 04 February 2016" @default.
- Q87232347 description "wetenschappelijk artikel" @default.
- Q87232347 description "наукова стаття, опублікована в лютому 2016" @default.
- Q87232347 name "Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer" @default.
- Q87232347 name "Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer" @default.
- Q87232347 type Item @default.
- Q87232347 label "Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer" @default.
- Q87232347 label "Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer" @default.
- Q87232347 prefLabel "Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer" @default.
- Q87232347 prefLabel "Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer" @default.
- Q87232347 P1433 Q87232347-6638042B-8E99-44AF-B7B7-CCAB1394860C @default.
- Q87232347 P1476 Q87232347-E199D824-BA17-4830-A80B-F7A39F40AE10 @default.
- Q87232347 P2093 Q87232347-6ACD0248-4A83-4A45-B90F-94372144C76B @default.
- Q87232347 P2093 Q87232347-B31CB23A-949D-4186-A5B1-B13AB3C09FE9 @default.
- Q87232347 P2093 Q87232347-B6795E83-EC0E-44B4-92DB-149D5745E6D5 @default.
- Q87232347 P2093 Q87232347-E7FA23BE-7190-4BD5-BEA1-9B3E6F125C67 @default.
- Q87232347 P2860 Q87232347-10274FE1-1281-4DF6-9849-F5C7CB06DB34 @default.
- Q87232347 P2860 Q87232347-11B85EE1-A7CA-408C-B0D3-D3BBD65B59EB @default.
- Q87232347 P2860 Q87232347-1459B9C9-CB4C-464A-A57B-A6FCB1A6A113 @default.
- Q87232347 P2860 Q87232347-3E1D9806-FF92-4559-887F-D173633D2EA3 @default.
- Q87232347 P2860 Q87232347-3FE919AD-1893-4389-85D9-AAD18CE27891 @default.
- Q87232347 P2860 Q87232347-49E736C5-C6A7-4862-BEE6-A755515B63F6 @default.
- Q87232347 P2860 Q87232347-50D62D6F-3F6F-4A56-BFAE-B813F9503334 @default.
- Q87232347 P2860 Q87232347-5E1EC5C9-85B5-4A2E-8B73-743F04CF246E @default.
- Q87232347 P2860 Q87232347-6238056B-8520-499D-8A94-5FAE6FE94CF7 @default.
- Q87232347 P2860 Q87232347-62828476-5FF5-434C-B681-32A3B07297F3 @default.
- Q87232347 P2860 Q87232347-6F344233-A842-4BB5-B588-E2AD1A37DCAD @default.
- Q87232347 P2860 Q87232347-7E697918-75A2-422F-85A1-FF42663BC8F2 @default.
- Q87232347 P2860 Q87232347-83AD1BA1-966B-4084-BA0C-B54BA51EF9B1 @default.
- Q87232347 P2860 Q87232347-A833687B-7EDF-402C-A11B-57E466A885B5 @default.
- Q87232347 P2860 Q87232347-AF520B5A-B631-46D6-9F28-01F8E5CFF206 @default.
- Q87232347 P304 Q87232347-452EFDE0-4C5E-4D0E-9D2E-8649C8D573BC @default.
- Q87232347 P31 Q87232347-979BA7CC-816B-4B6D-A558-4DD693F7E122 @default.
- Q87232347 P356 Q87232347-B7D724FD-3929-4D4E-8006-0B0CE149CA10 @default.
- Q87232347 P433 Q87232347-E190523F-F7EC-47E3-8D05-1C2648F689F7 @default.
- Q87232347 P478 Q87232347-B5C5158E-207A-4E9A-8050-A5EF6727BD8D @default.
- Q87232347 P577 Q87232347-66B2068D-0450-4E42-8082-AC80B4647C47 @default.
- Q87232347 P698 Q87232347-90529C37-5C1C-4CE1-A9B4-95F381A7A31C @default.
- Q87232347 P921 Q87232347-79FC6262-95FC-4EC4-A9FE-E43358A04289 @default.
- Q87232347 P356 S00520-016-3105-6 @default.
- Q87232347 P698 26847349 @default.
- Q87232347 P1433 Q15766919 @default.
- Q87232347 P1476 "Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer" @default.
- Q87232347 P2093 "Craig A Vargo" @default.
- Q87232347 P2093 "Ewa Mrozek" @default.
- Q87232347 P2093 "Gary Phillips" @default.
- Q87232347 P2093 "Michael J Berger" @default.
- Q87232347 P2860 Q29620676 @default.
- Q87232347 P2860 Q33739303 @default.
- Q87232347 P2860 Q33968076 @default.
- Q87232347 P2860 Q35878128 @default.
- Q87232347 P2860 Q37501868 @default.
- Q87232347 P2860 Q37671961 @default.
- Q87232347 P2860 Q37939458 @default.
- Q87232347 P2860 Q38125944 @default.
- Q87232347 P2860 Q39915208 @default.
- Q87232347 P2860 Q40095128 @default.
- Q87232347 P2860 Q40462527 @default.
- Q87232347 P2860 Q46610637 @default.
- Q87232347 P2860 Q50937762 @default.
- Q87232347 P2860 Q54394851 @default.
- Q87232347 P2860 Q74569553 @default.
- Q87232347 P304 "2913-2918" @default.
- Q87232347 P31 Q13442814 @default.
- Q87232347 P356 "10.1007/S00520-016-3105-6" @default.
- Q87232347 P433 "7" @default.
- Q87232347 P478 "24" @default.
- Q87232347 P577 "2016-02-04T00:00:00Z" @default.
- Q87232347 P698 "26847349" @default.
- Q87232347 P921 Q12859063 @default.